Legacy Good Samaritan Med Center is categorized under Hospitals in Portland, OR .
Legacy Good Samaritan Med Center was established in 0, and today employs 1 to 4, earning $100.000.000 to $499.999.999 per year. This is a Hospitals business, which does work in the B2C market, and is classified as a Hospitals, under code number 6221100 by the NAICS.
If you are seeking more information, feel free to contact Tony Melaragno, Manager at the company’s single location by writing to 1015 Nw 22nd Avenue, Portland, Oregon OR 97210 or by phoning (503) 413-7711. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Legacy Good Samaritan Med Center |
| Contact Person: | Tony Melaragno, Manager |
| Address: | 1015 Nw 22nd Avenue, Portland, Oregon 97210 |
| Phone Number: | (503) 413-7711 |
| Website Address: | legacyhealth.org |
| Annual Revenue (USD): | $100.000.000 to $499.999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hospitals |
| SIC Code: | 8062 |
| NAICS Code: | 6221100 |
| Share This Business: |
Legacy Good Samaritan Med Center was started in 0 to provide professional Hospitals under the SIC code 8062 and NAICS code 6221100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000.000 to $499.999.999 per annum.
Feel free to contact Tony Melaragno, Manager for inquiries that concern Legacy Good Samaritan Med Center by calling the company number (503) 413-7711, as your correspondence is most welcome. Additionally, the physical location of the single location of Legacy Good Samaritan Med Center can be found at the coordinates 45.53022,-122.69664 as well as the street address 1015 Nw 22nd Avenue in Portland, Oregon 97210.
For its online presence, you may visit Legacy Good Samaritan Med Center’s website at legacyhealth.org and engage with its social media outlets through on Twitter and on Facebook.